- Home
- ANVS vs ONMD Comparison
ANVS vs ONMD Comparison
Compare ANVS & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- ONMD
- Stock Information
- Founded
- ANVS 2008
- ONMD 2006
- Country
- ANVS United States
- ONMD United States
- Employees
- ANVS N/A
- ONMD N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- ANVS Health Care
- ONMD
- Exchange
- ANVS Nasdaq
- ONMD Nasdaq
- Market Cap
- ANVS 48.3M
- ONMD 43.5M
- IPO Year
- ANVS 2020
- ONMD N/A
- Fundamental
- Price
- ANVS $2.19
- ONMD $2.66
- Analyst Decision
- ANVS Strong Buy
- ONMD
- Analyst Count
- ANVS 4
- ONMD 0
- Target Price
- ANVS $17.33
- ONMD N/A
- AVG Volume (30 Days)
- ANVS 643.3K
- ONMD 15.5M
- Earning Date
- ANVS 11-07-2025
- ONMD 08-13-2025
- Dividend Yield
- ANVS N/A
- ONMD N/A
- EPS Growth
- ANVS N/A
- ONMD N/A
- EPS
- ANVS N/A
- ONMD N/A
- Revenue
- ANVS N/A
- ONMD $459,000.00
- Revenue This Year
- ANVS N/A
- ONMD N/A
- Revenue Next Year
- ANVS N/A
- ONMD N/A
- P/E Ratio
- ANVS N/A
- ONMD N/A
- Revenue Growth
- ANVS N/A
- ONMD N/A
- 52 Week Low
- ANVS $1.11
- ONMD $0.30
- 52 Week High
- ANVS $10.54
- ONMD $3.67
- Technical
- Relative Strength Index (RSI)
- ANVS 46.30
- ONMD 83.43
- Support Level
- ANVS $1.88
- ONMD $2.13
- Resistance Level
- ANVS $2.51
- ONMD $2.88
- Average True Range (ATR)
- ANVS 0.14
- ONMD 0.35
- MACD
- ANVS 0.02
- ONMD 0.17
- Stochastic Oscillator
- ANVS 47.28
- ONMD 63.03
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.